Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from TG Therapeutics

TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

TG Therapeutics (NASDAQ:TGTX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review

The stock market surged to highs on Donald Trump's election win. A Fed rate cut and a slew of big earnings reports filled out a busy week.

Investors Business Daily

TG Therapeutics Crashes — Reversing A Breakout — After Missing 'Whisper' Expectations

TG Therapeutics stock crashed Monday after missing profit expectations, though sales of its multiple sclerosis treatment beat forecasts.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

AI Stocks Meta, Oracle Lead Five Names Near Buy Points

Two of the five top stocks to watch this week target the artificial intelligence market.

Investors Business Daily

As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report

Amid the election, and a Fed rate vote, earnings season roars ahead.

Investors Business Daily

Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)

The Dow, S&P 500 and Nasdaq closed 0.3% lower.

Investors Business Daily

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter

TG Therapeutics stock broke out Monday less than two weeks after the biotech company reported a surprise profit for the June quarter.

Investors Business Daily

IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability

TG Therapeutics stock is the IBD Stock Of The Day as shares approach two potential entries on newfound profitability and booming sales.

Investors Business Daily

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review

Monday's global sell-off turned into a stock market rally attempt. Palantir, Eli Lilly and Fortinet were among the earnings winners.

Investors Business Daily

TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%

TG Therapeutics stock popped Tuesday after the drugmaker unexpectedly reported a second-quarter profit, thanks to significantly lower R&D.

Investors Business Daily

Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area

Among the best stocks to watch, biotech leader TG Therapeutics is clearing a key resistance area on the stock market today.

Investors Business Daily

TG Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating

TG Therapeutics sees its Relative Strength Rating hit the elite 90-plus level.

Investors Business Daily

TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?

TG Therapeutics shares soared Wednesday after sales of its multiple sclerosis treatment met expectations. TGTX stock topped its 200-day line.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

TG Therapeutics Reverses Its 225% Winning Streak On Lackluster Guidance

Sales of a new multiple sclerosis drug from TG crushed analysts' expectations, but TGTX stock tumbled on lackluster 2024 guidance.

Investors Business Daily

TG Therapeutics Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating

TG Therapeutics sees its Relative Strength Rating move into the elite 90-plus level.

Investors Business Daily

Sales Of TG Therapeutics' New Product Doubled — Here's Why Shares Halved

Sales of TG Therapeutics' highly anticipated multiple sclerosis drug, Briumvi, missed forecasts on Tuesday and TGTX stock plummeted.

Investors Business Daily

How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg

Roche unveiled positive results Thursday for a rival to TG Therapeutics' infusion for multiple sclerosis patients, and TGTX stock crashed.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall: Tesla Runs On GM Charging Deal; Boeing, Apple Chipmaker In Buy Areas

The market rally showed constructive action Thursday. Boeing and Apple chipmaker Taiwan Semiconductor are in buy areas. Red-hot Tesla ran late on a GM charging deal.

Investors Business Daily

Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets

TG Therapeutics more than doubled Wall Street's first-quarter sales expectations on Monday, and TGTX stock rocketed to a five-month high.

Investors Business Daily

Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales

TG Therapeutics' new MS drug, Briumvi, experienced a "solid jump" in March sales, according to a report. TGTX stock broke out Tuesday.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations